PeptideStack
5.2kquestions
20kanswers
220users

What did the placebo arm of STEP 2 report for vomiting?

Asked 11 Aug 2024Modified 2.0 years agoViewed 16k times
38

What I am working with: STEP 2 · vomiting.

I would like help reading this properly rather than being told what conclusion to reach.

I have the full report including the method section, so I can quote specifics if that helps.

How should I read this, and where are the traps?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questionsvomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
shareeditfollowflag
SB
askedseamus_brady15k1811 Aug 2024
2Can you link the publication rather than the summary? The summary usually drops the interval. – sunniva_dahl 5 months ago
3Is this the randomised phase or the open-label extension? – assay_blank 7 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 16k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.